Furthermore, APS inhibited the migration of Treg cells to the tumour microenvironment by blocking the SDF-1/CXCR4 signalling pathway, thereby reversing the immunosuppressive microenvironment in liver cancer and offering a novel strategy for immunotherapy. This evidence concerns the gene CXCL12 and neoplasm.